Semaglutide is gaining traction as a novel treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to produce more insulin and https://lancerocd822308.aioblogs.com/88539798/comprehending-semaglutide-a-comprehensive-guide